Clinical Trials
6 trialsNCT02314169 2026-05-28
Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04166318 2026-05-05
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
NCT02437851 2026-04-20
Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
AIDS Malignancy Consortium
Phase 2 Completed
NCT03403465 2026-02-27
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Duke University
Phase 2 Active not recruiting
NCT06640283 2025-12-24
ANA
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT05040815 2025-10-02
INSPIRE
AHS Cancer Control Alberta
Phase 2 Recruiting